Maravai Lifesciences Holdings (MRVI) Invested Capital (2020 - 2026)

Maravai Lifesciences Holdings' Invested Capital history runs 6 years deep, the most recent figure standing at $5.4 million for Q1 2026.

• In Q1 2026, Invested Capital changed 0.0% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $47.4 million (down 1.64% YoY), while the FY2025 annual figure was $31.1 million, down 2.48% from the prior year.
• Invested Capital for Q1 2026 stood at $5.4 million, down from $31.1 million in the prior quarter.
• The five-year high for Invested Capital was $34.7 million in Q1 2022, with the low at $5.4 million in Q3 2022.
• The 5-year median for Invested Capital is $5.4 million (2022), against an average of $17.4 million.
• Peak annual rise in Invested Capital reached 2576.96% in 2022, while the deepest fall reached 84.38% in 2022.
• Maravai Lifesciences Holdings' Invested Capital stood at $5.4 million in 2022, then soared by 497.98% to $32.5 million in 2023, then dropped by 1.94% to $31.9 million in 2024, then decreased by 2.48% to $31.1 million in 2025, then tumbled by 82.51% to $5.4 million in 2026.
• Business Quant data shows MRVI's Invested Capital at $5.4 million in Q1 2026, $31.1 million in Q4 2025, and $5.4 million in Q3 2025.